Reserpine
50-55-5
99%
2026-07-27
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Reserpine Cat No CEI-0378 Description Reserpine CAS No 50-55-5 Molecular Weight 608.68 Purity >99% Storage 2 years at -20 centigrade Targets Multidrug efflux pumps Molecular Formula C33H40N2O9 Chemical Name 11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester Solubility DMSO 13 mg/mL, Water In vitro Reserpine is an indole alkaloid antipsychotic and antihypertensive drug that has been used for the control of high blood pressure and for the relief of psychotic symptoms, although because of the development of better drugs for these purposes and because of its numerous side-effects, it is rarely used today. Reserpine acts by blocking the vesicular monoamine transporter VMAT, which normally transports free norepinephrine, serotonin, and dopamine from the cytoplasm of the presynaptic nerve into vesicles for subsequent release into the synaptic cleft. The unprotected neurotransmitters are then metabolized by MAO and therefore never reach the synapse. category Circulatory System Drugs(c1427) cas_num 50-55-5 Basic Info-
Product Name:
(-)-Reserpine
Other Name:Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-,methyl ester,(3β,16β,17α,18β,20α)-;3β,20α-Yohimban-16β-carboxylic acid,18β-hydroxy-11,17α-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester);3β,20α-Yohimban-16β-carboxylic acid,18β-hydroxy-11,17α-dimethoxy-,methyl ester,3,4,5-trimethoxybenzoate;Benz[g]indolo[2,3-a]quinolizine,yohimban-16-carboxylic acid deriv.;Anquil;Banasil;Bioserpine;Crystoserpine;Elserpine;Eserpine;Eskaserp;Kitine;Lemiserp;Loweserp;Mayserpine;Reserpic acid methyl ester 3,4,5-trimethoxybenzoate (ester);Methyl reserpate 3,4,5-trimethoxybenzoate (ester);Quiescin;Raucap;Raulen;Raurine;Rau-sed;Rausedil;Rausedyl;Rausingle;Resercen;Reserpamed;Reserpex;Reserpine;Reserpoid;Resine;Respital;Restran;Riserpa;Rivasin;Roxinoid;Sandril;Sedaraupin;Serfin;Serolfia;T-Serp;Serpaloid;Serpanray;Serpasil;Serpate;Serpen;Serpentina;Serpicon;Serpiloid;Sertabs;Sertina;3,4,5-Trimethoxybenzoyl methyl reserpate;Vio-Serpine;Raupasil;Serpine (pharmaceutical);ENT 50146;Serpasil premix;Raunervil;Reserlor;Sedserp;Serpipur;Temposerpine;Serp-AFD;Resercaps;Reserpil;Triserpin;Rauwasedin;Apoplon;Serpasol;Serpine;Carpacil;Hiposerpil;Deserpine;11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester;(-)-Reserpine;Serpasil Serpasol;NSC 237659;NSC 59272;1407-38-1;8048-25-7;141099-49-2;873409-80-4;909883-12-1;911481-85-1
CAS No.:50-55-5
Molecular Formula:C33H40N2O9
InChIKeys:InChIKey=QEVHRUUCFGRFIF-MDEJGZGSSA-N
Molecular Weight:608.68
Exact Mass:608.68
BRN:102014
EC Number:200-047-9
HScode:3003909090
Categories:
Characteristics-
PSA:
118
XLogP3:3.2
Appearance:Reserpine appears as white or cream to slightly yellow crystals or crystalline powder. Odorless with a bitter taste. (NTP, 1992)
Density:1.3±0.1 g/cm3
Melting Point:264.5 °C
Boiling Point:700.1±60.0 °C at 760 mmHg
Flash Point:22℃
Refractive Index:177 ° (C=1, DMF)
Water Solubility:soluble in water.
Storage Conditions:2-8°C
Toxicity:LD50 oral in rat: 420mg/kg
Specific rotation:D23 -118° (CHCl3); D26 -164° (c = 0.96 in pyridine); D26 -168° (c = 0.624 in DMF)
Odor:Odorless
PKA:6.6None
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Preparations containing Rauwolfia alkaloids should be stored in light-resistant containers. Rauwolfia alkaloids
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
